Roberto Ferrara

Roberto Ferrara is a Researcher in Medical Oncology at the Università Vita-Salute San Raffaele. His work focuses on immunotherapy, lung cancer, and biomarker development, with a particular emphasis on non-small cell lung cancer (NSCLC) and treatment response prediction.

Recent research includes the application of machine learning to immunotherapy outcomes in metastatic NSCLC, robotic surgery safety in elderly lung cancer patients, and the role of circulating tumor DNA in monitoring lorlatinib efficacy for ALK-positive NSCLC. His studies also explore viral drivers of immune senescence and sex-based differences in immunotherapy responses.

He contributes to clinical education in oncology, teaching advanced topics to medical students in the Laurea Magistrale in Medicina e Chirurgia program. His publications span journals like Journal of Thoracic Oncology and Science Advances, reflecting interdisciplinary approaches to cancer care.